ABSORPTION OF BETA-ADRENERGIC-BLOCKING AGENT, NADOLOL, BY MICE, RATS, HAMSTERS, RABBITS, DOGS, MONKEYS, AND MAN - UNUSUAL SPECIES-DIFFERENCE

被引:24
作者
DREYFUSS, J
SHAW, JM
ROSS, JJ
机构
关键词
D O I
10.3109/00498257809056152
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:503 / 508
页数:6
相关论文
共 11 条
[1]   CLINICAL EXPERIENCE WITH ACTINOMYCIN-C [J].
BEGEMANN, H .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 89 (02) :454-462
[3]   METABOLIC STUDIES IN PATIENTS WITH NADOLOL - ORAL AND INTRAVENOUS ADMINISTRATION [J].
DREYFUSS, J ;
BRANNICK, LJ ;
VUKOVICH, RA ;
SHAW, JM ;
WILLARD, DA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (5-6) :300-307
[4]  
HANDSCHUMACHER RE, 1962, CANCER CHEMOTH REP, P267
[5]   EFFECT OF SELECTIVE ACYLATION ON ORAL ABSORPTION OF A NUCLEOSIDE BY HUMANS [J].
HOEKSEMA, H ;
WHITFIELD, GB ;
RHULAND, LE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1961, 6 (03) :213-+
[6]  
LEE RJ, 1973, FED PROC, V32, P780
[7]  
SMITH C G, 1973, Journal of International Medical Research, V1, P489
[8]  
VUKOVICH R, 1976, CLIN RES, V24, pA513
[9]  
WALLACH DONALD P., 1959, ANTIBIOT AND CHEMOTHER, V9, P722
[10]  
WONG K K, 1972, Drug Metabolism Reviews, V1, P101, DOI 10.3109/03602537208993910